"10.1371_journal.pone.0086745","plos one","2014-02-19T00:00:00Z","Moushimi Amaya; Kelsey Voss; Gavin Sampey; Svetlana Senina; Cynthia de la Fuente; Claudius Mueller; Valerie Calvert; Kylene Kehn-Hall; Calvin Carpenter; Fatah Kashanchi; Charles Bailey; Soren Mogelsvang; Emanuel Petricoin; Aarthi Narayanan","National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America; Center for Applied Proteomics and Personalized Medicine, George Mason University, Manassas, Virginia, United States of America; Serpin Pharma LLC, Manassas, Virginia, United States of America","Conceived and designed the experiments: MA FK SM CB AN. Performed the experiments: MA KV GS SS CF KKH CC VC AN. Analyzed the data: MA CM SM EP AN. Contributed reagents/materials/analysis tools: KKH EP CB AN. Wrote the paper: MA AN.","The authors association with Serpin Pharma is strictly academic with the emphasis on NFkB activation in VEEV infections. None of the authors included in the paper (that are not from Serpin Pharma) have any conflicting interests relating to employment, consultancy, patents, products in development or marketed products etc. The authors association with Serpin Pharma does not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Moushimi Amaya","MA",14,TRUE,5,9,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
